| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| Fr | Catheter Precision, Inc. - 8-K, Current Report | 1 | SEC Filings | ||
| 22.01. | Catheter Precision, Inc.: Catheter Precision Receives First Purchase Order for LockeT in Germany | 743 | GlobeNewswire (Europe) | FORT MILL, S.C., Jan. 22, 2026 (GLOBE NEWSWIRE) -- Catheter Precision, Inc. (VTAK - NYSE/American), a US based medical device company focused on developing technologically advanced products for the... ► Artikel lesen | |
| 20.01. | Catheter Precision, Inc.: Catheter Precision Received new VIVO Purchase Order from Leading Hospital in Slovenia | 4 | GlobeNewswire (USA) | ||
| 25.11.25 | Catheter Precision, Inc.: Historic Win for Electrophysiology Reimbursement in Ambulatory Surgery Centers Provides Unique Opportunity for Catheter Precision's LockeT Device | 961 | GlobeNewswire (Europe) | FORT MILL, S.C., Nov. 25, 2025 (GLOBE NEWSWIRE) -- Catheter Precision, Inc. (VTAK - NYSE/American), a US based medical device company focused on developing technologically advanced products for the... ► Artikel lesen | |
| 21.11.25 | Catheter Precision, Inc. - 8-K, Current Report | - | SEC Filings | ||
| 14.11.25 | Catheter Precision, Inc. - 8-K, Current Report | - | SEC Filings | ||
| 13.11.25 | Catheter Precision reports Q3 results | 1 | Seeking Alpha | ||
| 13.11.25 | Catheter Precision, Inc.: Catheter Precision (VTAK) Reports Third Quarter and First Nine Months 2025 Results of Operations | 702 | GlobeNewswire (Europe) | FORT MILL, S.C., Nov. 13, 2025 (GLOBE NEWSWIRE) -- Catheter Precision, Inc. (NYSE American: VTAK), a U.S.-based innovative medical device company focused on the cardiac electrophysiology marketplace... ► Artikel lesen | |
| CATHETER PRECISION Aktie jetzt für 0€ handeln | |||||
| 13.11.25 | Catheter Precision, Inc. - 10-Q, Quarterly Report | - | SEC Filings | ||
| 16.10.25 | Catheter Precision, Inc.: Catheter Precision Enters Distribution Agreement with FuMedica AG to Bring LockeT to Switzerland | 224 | GlobeNewswire (Europe) | FORT MILL, S.C., Oct. 16, 2025 (GLOBE NEWSWIRE) -- Catheter Precision, Inc. (VTAK - NYSE/American), a US based medical device company and a leading developer of innovative solutions for cardiac procedures... ► Artikel lesen | |
| 15.10.25 | Catheter Precision, Inc. - 8-K, Current Report | 1 | SEC Filings | ||
| 30.09.25 | Catheter Precision, Inc. Announces Two New Patents to be Issued by USPTO | 189 | GlobeNewswire (Europe) | FORT MILL, S.C., Sept. 30, 2025 (GLOBE NEWSWIRE) -- Catheter Precision, Inc. (VTAK - NYSE/American), a US based medical device company focused on developing technologically advanced products for the... ► Artikel lesen | |
| 10.09.25 | Catheter Precision, Inc.: Catheter Precision Announces Tender Win and First Purchase Order in Croatia | 1.141 | GlobeNewswire (Europe) | FORT MILL, S.C., Sept. 10, 2025 (GLOBE NEWSWIRE) -- Catheter Precision, Inc. (VTAK - NYSE/American), a US based medical device company focused on developing technologically advanced products for the... ► Artikel lesen | |
| 04.09.25 | Catheter Precision, Inc.: Catheter Precision Announces September 10th, 2025 Record Date for October 10th, 2025 Special Meeting of Stockholders | 1 | GlobeNewswire (USA) | ||
| 28.08.25 | Catheter Precision, Inc.: Catheter Precision Announces First Procedures in France as LockeT Expansion Continues | 1 | GlobeNewswire (USA) | ||
| 21.08.25 | Catheter Precision, Inc.: Catheter Precision Announces the Start of Enrollment for the LockeT Compare Study | 2 | GlobeNewswire (USA) | ||
| 18.08.25 | Catheter Precision, Inc. - 8-K, Current Report | 2 | SEC Filings | ||
| 18.08.25 | Catheter Precision's LockeT Wound Closure Device Approved In UK; Shares Soar Over 65% | 1 | RTTNews | ||
| 15.08.25 | Catheter Precision executes 1-for-19 reverse stock split | 2 | Seeking Alpha | ||
| 15.08.25 | Catheter Precision, Inc. Announces Effectiveness of 1-for-19 Reverse Stock Split | 518 | GlobeNewswire (Europe) | FORT MILLS, S.C., Aug. 15, 2025 (GLOBE NEWSWIRE) -- Catheter Precision, Inc. (NYSE American: VTAK), a US based medical device company focused on developing technologically advanced products for... ► Artikel lesen |
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| FRESENIUS | 49,760 | +1,06 % | Fresenius: 2026 setzt sich das Wachstum fort | Am 25. Februar wird Fresenius Zahlen zum vierten Quartal publizieren. Die Analysten der DZ Bank rechnen mit einer soliden Entwicklung. Wachstumsinvestitionen bei Kabi dürften sich bei den Margen bemerkbar... ► Artikel lesen | |
| FRESENIUS MEDICAL CARE | 40,640 | +0,40 % | DAX-Check LIVE: Fresenius Medical Care, Nordex, Puma, Sartorius Vz., Schaeffler, Siltronic im Fokus | Ein kurzzeitiger Ausverkauf bei Gold und Silber hat den DAX zum Wochenstart zunächst belastet. Die Unsicherheit beruhigte sich jedoch im Tagesverlauf, auch unterstützt durch eine Erholung an den US-Märkten.... ► Artikel lesen | |
| ECKERT & ZIEGLER | 15,440 | +1,65 % | Picks and shovels play intact, chg.: FY25 prelims confirm Eckert & Ziegler's earnings momentum, with China and isotope ... | Novo Nordisk's c.17% share price drop underscores how quickly sentiment can turn in single product healthcare stories, especially when patent cycle concerns resurface. In contrast, EUZ is "picks and... ► Artikel lesen | |
| BICO GROUP | 1,594 | -0,25 % | BICO Group AB: BICO company Biosero launches GoSimple, a standardized automation-ready workcell with selected instruments from Sartorius and Becton, Dickinson and Company (BD) | Biosero, part of the BICO Group and a leader in lab automation, will launch the GoSimple workcell at SLAS 2026 (February 7-11, Boston, US). GoSimple is a standardized, automation-ready workcell designed... ► Artikel lesen | |
| SERNOVA BIOTHERAPEUTICS | 0,086 | -7,53 % | Sernova Biotherapeutics Closes First Tranche of a Private Placement of Equity Financing to Support Ongoing Clinical Efforts | Toronto, Ontario and Boston, Massachusetts--(Newsfile Corp. - November 13, 2025) - Sernova Biotherapeutics (TSX: SVA) (OTC: SEOVF) (FSE: PSH) ("Sernova or the Company)") a leading regenerative medicine... ► Artikel lesen | |
| RESMED | 228,30 | -0,65 % | Why Brambles, HMC Capital, ResMed, and Rio Tinto shares are rising today | ||
| CARDINAL HEALTH | 194,00 | +1,33 % | ROUNDUP: Cardinal Health Boosts FY26 Adj. EPS Outlook; Shares Up 3.4% | WASHINGTON (dpa-AFX) - While reporting financial results for the second quarter on Thursday, healthcare services company Cardinal Health, Inc. (CAH) raised its adjusted earnings guidance for... ► Artikel lesen | |
| ATOSSA THERAPEUTICS | 0,001 | -100,00 % | XFRA NEW INSTRUMENTS AVAILABLE ON 02.02.2026 | The following instruments on XETRA do have their first trading 02.02.2026 Die folgenden Instrumente in XETRA haben ihren ersten Handelstag 02.02.2026
Aktien
1 CA00249P1053 AXA S.A. CDR
2 ARP125991090... ► Artikel lesen | |
| ZIMMER BIOMET | 74,90 | -1,53 % | Zimmer Biomet gets FDA nod for newest addition to G7 hip implant line | ||
| UNIDOC HEALTH | 0,083 | -8,73 % | UniDoc stellt Installation des H3 Health Cube in Italien fertig | - Der KI-gestützte Health Cube steht
ab sofort den Patienten im Dorf Guardia Perticara in der italienischen Region Basilikata zur Verfügung.
VANCOUVER, British Columbia... ► Artikel lesen | |
| SONOMA PHARMACEUTICALS | 2,480 | -100,00 % | Sonoma Pharmaceuticals, Inc.: Sonoma Pharmaceuticals Welcomes New Member of its Board of Directors and New Senior Vice President of Regulatory, Quality and Product Development | BOULDER, CO / ACCESS Newswire / January 28, 2026 / Sonoma Pharmaceuticals, Inc. (Nasdaq:SNOA), a global healthcare leader developing and producing patented Microcyn technology based stabilized hypochlorous... ► Artikel lesen | |
| CO-DIAGNOSTICS | 0,172 | 0,00 % | XFRA DELETION OF INSTRUMENTS FROM BOERSE FRANKFURT - 22.01.2026 | The following instruments on Boerse Frankfurt do have their last trading day on 22.01.2026Die folgenden Instrumente in Boerse Frankfurt haben ihren letzten Handelstag am 22.01.2026ISIN NameCA74290F1009 PROBE... ► Artikel lesen | |
| CYTOSORBENTS | 0,575 | -0,86 % | Cytosorbents Corp: CytoSorbents Reports Preliminary Unaudited Fourth Quarter and Full-Year 2025 Results and Business Update | Fourth quarter and Full-Year 2025 revenue are expected to be approximately $9.2 million and $37.0 million, respectively, with expected Q4 gross margins in the range... ► Artikel lesen | |
| VERU | 2,340 | +4,46 % | Veru Inc.: Veru to Report Fiscal 2026 First Quarter Financial Results on February 11th | ||
| CLARIANE | 3,900 | +1,30 % | Pflege braucht Vielfalt: Jetzt für den Korian Stiftungsaward 2026 bewerben | München (ots) - Die Korian Stiftung für Pflege und würdevolles Altern schreibt zum sechsten Mal ihren Award für Vielfalt und Respekt in der Pflege aus. Ausgezeichnet werden Einrichtungen, Pflegedienste... ► Artikel lesen |